4//SEC Filing
Guy Wendy 4
Accession 0000897069-24-001608
CIK 0001533743other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:12 PM ET
Size
18.0 KB
Accession
0000897069-24-001608
Insider Transaction Report
Form 4
Guy Wendy
Chief Administrative Officer
Transactions
- Award
Restricted Stock Units
2024-06-28+2,035→ 24,236 totalExercise: $0.00→ Common Stock (2,035 underlying) - Exercise/Conversion
Common Stock
2024-04-05+1,675→ 11,801 total - Tax Payment
Common Stock
2024-04-05$2.79/sh−368$1,027→ 11,433 total - Exercise/Conversion
Common Stock
2024-07-10+644→ 12,077 total - Tax Payment
Common Stock
2024-07-10$1.71/sh−220$376→ 11,857 total - Award
Restricted Stock Units
2024-06-28+2,713→ 22,201 totalExercise: $0.00→ Common Stock (2,713 underlying) - Award
Restricted Stock Units
2024-06-28+339→ 24,575 totalExercise: $0.00→ Common Stock (339 underlying) - Award
Restricted Stock Units
2024-06-28+339→ 24,914 totalExercise: $0.00→ Common Stock (339 underlying)
Holdings
- 8,335(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Distribution of vested restricted shares.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001799360
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:12 PM ET
- Size
- 18.0 KB